跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-TADALAFIL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-TADALAFIL
Authorized
STANDARD
TEVA-TADALAFIL
TEVA CANADA LIMITED
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
6c81019374e17fb1
Company
TEVA CANADA LIMITED
Type
Standard
Approval Details
Approval Id
6c81019374e17fb1
Drug Approval Canada Name
TEVA-TADALAFIL
Product Name
TEVA-TADALAFIL
Status
Marketed
Status Date
2016-07-12
Original Market Date
2016-07-12
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
PRESCRIPTION
Ahfs
24:12.12
Atc Original
G04BE08 TADALAFIL
Aig Number
0149485004
Company Name
TEVA CANADA LIMITED
Company Address
30 Novopharm Court Toronto Ontario Canada M1B 2K9
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
6c81019374e17fb1
Type
Standard
Back to Health Canada Approvals